February 7th, 2025
Surgeons Perform Second Pig Kidney Transplant at Massachusetts General Hospital
The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Startups
February 7th, 2025
The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.
December 18th, 2024
The mesosphere holds untapped data helpful for understanding climate change, and the possibility of new communication networks.
October 28th, 2024
With funding and support from the Climate and Sustainability Translational Fund, researchers will pursue green jet fuel, cleaner chemicals, sustainable packaging, and carbon storage.
October 2nd, 2024
Attivare Therapeutics, a Harvard startup out of the Wyss Institute, has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS), Dana-Farber Cancer Institute, and Massachusetts General Hospital. This technology creates an in vivo training ground for the immune system to fight cancer more effectively and prevent infection.
September 19th, 2024
GC Therapeutics (GCTx), a Harvard startup, announced its launch to scale and its technology TFome™, the world’s first “plug and play” induced pluripotent stem cell (iPSC) programming platform for cell therapies in multiple therapeutic areas.